KCNN4 and central nervous system cancer: In a preclinical study by Stransky et al. [210], irradiation-induced hyper-invasion of glioma cells appears to be quenched by combining radiotherapy with TRAM-34, a drug targeting KCa3.1, in preclinical immunocompetent glioma mouse models.